APA-referens

Liu, Z., Yao, W., Zhao, Y., Liu, O., Zhang, P., & Ge, H. (2021). Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas. Cancer Manag Res.

Chicago-stil citat

Liu, Zhiyong, Weitao Yao, Yao Zhao, Oufei Liu, Peng Zhang, och Hong Ge. "Efficacy and Safety of Anlotinib Combined With Liposomal Doxorubicin Followed By Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas." Cancer Manag Res 2021.

MLA-referens

Liu, Zhiyong, et al. "Efficacy and Safety of Anlotinib Combined With Liposomal Doxorubicin Followed By Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas." Cancer Manag Res 2021.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.